In general, FIRKO mice appeared to have an improved metabolic phenotype, were protected from hyperphagic obesity, had decreased adiposity, improved i.p. glucose tolerance, and altered leptin expression. The gene discussed is LEP; the disease is obesity due to melanocortin 4 receptor deficiency.